Top Markets
Coin of the day
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd

HLB Pharmaceutical Co., Ltd

047920
Classement en actions #19339
HLB Pharmaceutical Co., Ltd is a South Korean pharmaceutical firm dedicated to... HLB Pharmaceutical Co., Ltd is a South Korean pharmaceutical firm dedicated to the research and development of peptide-based drugs. Its product line encompasses a wide array of pharmaceutical preparations. These include medications for skeletal muscle relaxation, tranquilizing effects, antihistamine action, hypertension management, pain alleviation, anti-itching, astringent properties, anti-inflammatory relief, alimentary system support, metabolic regulation, ophthalmic conditions, local anesthesia, anti-arteriosclerosis, expectoration, fever reduction, analgesia, diabetes control, chemotherapy, peptic ulcer treatment, central nervous system issues, bacterial infections (antibiotics), digestive assistance, antacid needs, dental care, multivitamin supplementation, parasitic skin diseases, dermatological concerns, urogenital organ function, amino acid replacement, cough suppression, mucus thinning, parasitic worm elimination, diarrhea relief, circulatory system disorders, vitamin deficiencies, skin softening, hemorrhoid treatment, and liver ailments. Additionally, the company is actively developing CTT-004, an investigational therapy for ataxia associated with spinocerebellar degeneration, and offers Contract Manufacturing Organization (CMO) services. The enterprise, established in 1998, was formerly recognized as Mediforum Pharmaceutical Incorporation before adopting the name HLB Pharmaceutical Co., Ltd in October 2020. Its headquarters are located in Namyangju-Si, South Korea.
Prix de l'action
$5.04
Capitalisation boursière
$165.34M
Changement (1 jour)
-4.46%
Changement (1 an)
-48.26%
Pays
KR
Échange HLB Pharmaceutical Co., Ltd (047920)

Catégorie

Le prix 047920 avec la capitalisation boursière de B
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
047920
$5.04
Capitalisation boursière de HLB Pharmaceutical Co., Ltd(047920)
Capitalisation boursière: $165.34M
En August 2026, HLB Pharmaceutical Co., Ltd a une capitalisation boursière de $165.34M. Cela fait de HLB Pharmaceutical Co., Ltd la 19339th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de HLB Pharmaceutical Co., Ltd du 2015 au 2026
047920 par rapport au top 5 des plus populaires stocks
Prix pour 047920 L’actif B La capitalisation boursière de B Résultats
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$157,094 $165.34M
$5.152T +3,116,225.47%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$138,329 $165.34M
$4.537T +2,743,979.31%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$127,095 $165.34M
$4.169T +2,521,131.61%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$111,051 $165.34M
$3.642T +2,202,865.08%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$85,512.30 $165.34M
$2.805T +1,696,240.01%